Odyssey Therapeutics, Inc.
"is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. Its programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. "
----------------------------------
Multiple Time-Frame Analysis; Color Code.
Strength favors the higher timeframe.
Yearly timeframe = black
Monthly timeframe = pink
weekly = grey
daily = red
4hr = orange
1hr = yellow
15min = blue
5min = green if they are shown. (Level visibility on intervals is set to timeframe the level was found on and below to keep chart view organized.)
"is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. Its programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. "
----------------------------------
Multiple Time-Frame Analysis; Color Code.
Strength favors the higher timeframe.
Yearly timeframe = black
Monthly timeframe = pink
weekly = grey
daily = red
4hr = orange
1hr = yellow
15min = blue
5min = green if they are shown. (Level visibility on intervals is set to timeframe the level was found on and below to keep chart view organized.)
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.